en · de · es · pt
melanotan-2-notes.peptides7501.com › Topic › Melanotan-2 Identity And Receptor Pharmacology — Practical Notes

Melanotan-2 Identity And Receptor Pharmacology — Practical Notes

By Editorial Desk · published 2026-02-03 · last reviewed 2026-03-07 · Topic

synthetic peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-03-07. Where a claim depends on a specific study, the study is described rather than over-claimed.

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Background and Chemical Profile

The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.

Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.

Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.

Melanotan-2 at a glance

PropertyValueNotes
Common synonymsMelanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amideNaming follows peptide convention; the numeral distinguishes it from melanotan-1
Molecular formulaC50H69N15O9Includes the lactam bridge; no counter-ion assumed
Monoisotopic mass1023.53 DaFree base; salts and counter-ions shift the observed value
AppearanceWhite to off-white lyophilised powderBatch-to-batch colour variation is not itself proof of impurity
Typical analytical methodRP-HPLC purity determination with ESI-MS identity confirmationRetention time alone does not establish sequence identity

Origins and Research Status

The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.

Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.

Related pages on this site

Background and Receptor Mechanism

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Reference notes

==== Types of drug controls ==== There are two different types of controls that can be conducted in competition or in training. It is important that tests are conducted by independent organizations that treat each athlete equally, indifferent of fame or nationality.

While arginine, glutamine and other amino acids are rapidly consumed often very early in fermentation, proline is not consumed by yeast at all during the normal, anaerobic conditions of fermentations. This is because one of the enzymes required for its use is an oxidase (requiring molecular oxygen) and the other is repressed by the presence of ammonium (another source of assimilable nitrogen needed by yeast) in the must. However, well aerated starter cultures that contain must which hasn't had any diammonium phosphate added it to it will usually see some utilization of proline before the anaerobic conditions of fermentation kick in. When winemakers measure FAN, they need to be aware if their assay is including proline since this will make their YAN measurement higher. Chardonnay and Cabernet Sauvignon are two Vitis vinifera varieties that are known to have very high proline levels while Riesling and Sauvignon blanc usually have very low levels. Yeast transport amino acids and small peptides (less than 5 amino acid residues) into the cell via an active transport process that utilizes specialized membrane proteins and the difference in the pH gradient of the acidic wine solution (pH between 3-4) and the near neutral pH of cytoplasm inside the yeast cells. The proton symport proteins in the membrane take in the amino acid coupled with a hydrogen ion that later gets expelled by the cell via a hydrogen ion pump.

== Definition == An element of a flowing liquid or gas will endure forces from the surrounding fluid, including viscous stress forces that cause it to gradually deform over time. These forces can be mathematically first order approximated by a viscous stress tensor, usually denoted by

==== Environmental effects ==== The way in which new structures mature as they are produced may be affected by the point in the plant's life when they begin to develop, as well as by the environment to which the structures are exposed. This can be seen in aquatic plants.

The Elementary Osmotic Pump (EOP) was developed by ALZA in 1974, and was the first practical example of an osmotic pump based drug release system for oral use. It was introduced to the market in the early 1980s in Osmosin (indomethacin) and Acutrim (phenylpropanolamine), but unexpectedly severe issues with GI irritation and cases of GI perforation led to the withdrawal of Osmosin. Merck & Co. later developed the Controlled-Porosity Osmotic Pump (CPOP) with the intention of addressing some of the issues that led to Osmosin's withdrawal via a new approach to the final stage of the release mechanism. Unlike the EOP, the CPOP had no pre-formed hole in the outer shell for the drug to be expelled out of. Instead, the CPOP's semipermeable membrane was designed to form numerous small pores upon contact with water through which the drug would be expelled via osmotic pressure. The pores were formed via the use of a pH insensitive leachable or dissolvable additive such as sorbitol.

Sources: en.wikipedia.org

Notes from published material

==== The Mariam Appeal ==== In 1998, Galloway founded the Mariam Appeal which was intended, according to its website's welcome page in 1999, "to campaign against sanctions on Iraq which are having disastrous effects on the ordinary people of Iraq". The campaign was named after Mariam Hamza, a child flown by the fund from Iraq to Britain to receive treatment for leukaemia. The intention was to raise awareness of the suffering and death of hundreds of thousands of other Iraqi children, due to poor health conditions and lack of suitable medicines and facilities, and to campaign for the lifting of the Iraq sanctions that many maintained were responsible for that situation. In 1999, Galloway was criticised for spending Christmas in Iraq with Tariq Aziz, who was Iraq's Deputy Prime Minister. In a 17 May 2005 hearing of the United States Senate Committee on Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations, Galloway stated that he had many meetings with Aziz, and characterised their relationship as friendly. He said at another occasion that he and Aziz met more than ten times. During the 2003 invasion of Iraq, the fund received scrutiny after a complaint that Galloway used some donated money to pay for his travel expenses. He responded by stating that the expenses were incurred in his capacity as the appeal's chairman. Although the Mariam Appeal was never a registered charity and never intended to be such, it was investigated by the Charity Commission.

Hydroxymethylfurfural (HMF), also known as 5-(hydroxymethyl)furfural, is an organic compound formed by the dehydration of reducing sugars. It is a white low-melting solid (although commercial samples are often yellow) which is highly soluble in both water and organic solvents. The molecule consists of a furan ring, containing both aldehyde and alcohol functional groups. HMF can form in sugar-containing food, particularly as a result of heating or cooking. Its formation has been the topic of significant study as HMF was regarded as being potentially carcinogenic to humans. However, so far in vivo genotoxicity was negative. No relevance for humans concerning carcinogenic and genotoxic effects can be derived. HMF is classified as a food improvement agent and is primarily being used in the food industry in form of a food additive as a biomarker as well as a flavoring agent for food products. It is also produced industrially on a modest scale as a carbon-neutral feedstock for the production of fuels and other chemicals.

alpha helix (α-helix) A common structural motif in the secondary structures of proteins consisting of a right-handed helix conformation resulting from hydrogen bonding between amino acid residues which are not immediately adjacent to each other.

In his introduction to the 1895 edition of Karl Marx's The Class Struggles in France, Engels attempted to resolve the division between gradualist reformist and revolutionary socialists in the Marxist movement by declaring that he was in favour of short-term tactics of electoral politics that included gradualist and evolutionary socialist policies while maintaining his belief that revolutionary seizure of power by the proletariat should remain a key goal of the socialist movement. In spite of this attempt by Engels to merge gradualism and revolution, his effort only diluted the distinction of gradualism and revolution and had the effect of strengthening the position of the revisionists. Engels' statements in the French newspaper Le Figaro in which he argued that "revolution" and the "so-called socialist society" were not fixed concepts, but rather constantly changing social phenomena and said that this made "us [socialists] all evolutionists", increased the public perception that Engels was gravitating towards evolutionary socialism. Engels also wrote that it would be "suicidal" to talk about a revolutionary seizure of power at a time when the historical circumstances favoured a parliamentary road to power which he predicted could happen "as early as 1898." Engels' stance of openly accepting gradualist, evolutionary and parliamentary tactics while claiming that the historical circumstances did not favour revolution caused confusion among political commentators and the public.

Sources: en.wikipedia.org

Further detail

G cells have a distinctive microscopic appearance that allows one to separate them from other cells in the gastric antrum; their nuclei are centrally located in the cell. They are found in the middle portion of the gastric glands.

Wilhelm Röntgen's discovery of X-rays in 1895 led to the use of radiographs to locate bullets in wounded soldiers. Survival rates for gunshot wounds improved among US military personnel during the Korean and Vietnam Wars, due in part to helicopter evacuation, along with improvements in resuscitation and battlefield medicine. Similar improvements were seen in US trauma practices during the Iraq War. Military health care providers who return to civilian practice sometimes disseminate military trauma care practices. One such practice is to transfer major trauma cases to an operating theater as soon as possible, to stop internal bleeding. Within the United States, the survival rate for gunshot wounds has increased, leading to declines in the gun death rate in states that have stable rates of gunshot hospitalizations.

== History == After the sale of KFC in 1964, Lee Cummings (the nephew of KFC founder Colonel Harland Sanders) began developing his recipe, later to be known as "Famous Recipe." In 1966, Cummings, along with Harold Omer, started "Harold's Take-Home" in Lima, Ohio, where Cummings first introduced his Famous Recipe Chicken. Later that year, Cummings opened the restaurant's first franchise in Columbus, Ohio. Locations in Springfield, Dayton, and Cincinnati, Ohio, followed in the coming years, as well as a unit in Kalamazoo, Michigan. In 1981, Cummings sold the chain to Shoney's Restaurants in Nashville, Tennessee. He died in 2002 at the age of 80. Shoney's continued to operate Lee's along with their own Captain D's and Shoney's Restaurants until 1995, when Lee's was sold to RTM Restaurant Group in Atlanta, Georgia. In May 2003, the chain had 29 company-owned locations and 125 franchised locations. In October 2003, Lee's Famous Recipes Inc. purchased the chain from RTM. In April 2013, Famous Recipe Group LLC purchased the chain from Lee's Famous Recipes, Inc. In June 2021, Famous Recipe Group, LLC, brand owner of Lee's Famous Recipe Chicken, agreed to sell the brand to LFR Chicken, LLC a new entity backed by Artemis Lane Partners.

== Chemical structure and properties == ECG is a flavonoid with a molecular formula of C22H18O10 and a molecular weight of 442.4 g/mol. Its structure comprises a flavan-3-ol backbone (epicatechin) esterified with gallic acid at the 3-position, featuring two catechol rings and a trihydroxybenzoate ring with multiple hydroxyl groups. In test tube experiments, the galloyl moiety enhances ECG's radical scavenging compared to epicatechin, with a DPPH assay showing higher antioxidant activity due to the additional hydroxyl groups. ECG is soluble in water, ethanol, and dimethyl sulfoxide, but degrades significantly in boiling water, limiting its stability in tea preparation.

The creation of URLs that will not change with time is the fundamental method of preventing link rot. Preventive planning has been championed by Tim Berners-Lee and other web pioneers. Berners-Lee recommended designing URIs to avoid details likely to change, such as authorship, subject matter, file extension, software mechanism, or access status. Strategies pertaining to the authorship of links include:

Sources: en.wikipedia.org

Frequently asked questions

What is melanotan-2 chemically?

It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.

How does it differ from the natural hormone?

The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.

Does it hold any regulatory approval?

No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.

What is melanotan-2?

It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.

Network